Figure 2From: Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cellsDetection of IPP and ApppI in breast cancer cells treated with various bisphosphonates. IPP (A) and ApppI (B) were measured in bisphosphonate-stimulated MCF-7 and T47D breast cancer cells. All data are expressed as means of three independent experiments ± SEM (ZA: zoledronic acid, RIS: risedronate, IBN: ibandronate, ALN: alendronate, n.d.: not detectable).Back to article page